{"schema":"sb.node.v1","id":"sb:e/cd30f295b64ab8277556ea54","kind":"entity","label":{"text":"iiib","locale":"en"},"identity":{"anchor":"label:en:iiib","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-10T19:00:35.865848+00:00","snapshot":"deploy b663cc8b34a8931137d702b8e11a6acd5fab341d"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":25,"separatePublishers":7,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"partial","share":0.24,"named":6,"of":25,"basis":"documents whose own title or summary lead names the subject, over every counted document that mentions it anywhere (the entity graph's measurement); receipts are drawn from the former only","blind":["only 24% of the 25 documents measured name the subject in their own text; the rest mention it in passing, so standing.evidence.supporting overstates coverage about it"]}},"admission":{"state":"provisional","reason":"entity graph provenance 'observed'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-08-25","to":"2026-10-09","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0: about 100% of mentions carry no typed assertion"]}},"dimensions":{"domains":["auto","fda_decisions","society_news"],"activeDays":19,"assertions":{}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":6,"byKind":{"observation":6},"items":[{"id":"sb:o/63ece5aa3b26a87720e265f7","kind":"observation","label":"Clinical Trials Arena · 2026-10-07 · ViiV Healthcare’s Cabenuva beats daily oral ART in Phase IIIb trial","url":"https://www.clinicaltrialsarena.com/news/viiv-healthcares-cabenuva-beats-daily-oral-art-in-phase-iiib-trial/"},{"id":"sb:o/5c8ec988bbb5e8ce53ce9a20","kind":"observation","label":"AllSci News · 2026-10-07 · Cabenuva shows potential to move beyond suppressed HIV patients after Phase IIIb win","url":"https://allsci.com/news/clinical-trials/cabenuva-hiv-treatment-beats-daily-oral-therapy/"},{"id":"sb:o/72179ef22acb8dc585157947","kind":"observation","label":"AllSci News · 2026-10-01 · Lilly's Ebglyss wins Phase IIIb trial in hand and foot atopic dermatitis, seeks label expansion","url":"https://allsci.com/news/clinical-trials/ebglyss-atopic-dermatitis-trial-lillys-wins-phase/"},{"id":"sb:o/6604e55449a5f7f8ce24e5e4","kind":"observation","label":"Clinical Trials Arena · 2026-09-21 · Otsuka reports expanded Phase IIIb results for Simtriyo in adult ADHD","url":"https://www.clinicaltrialsarena.com/news/otsuka-simtriyo-phase-iiib-results/"},{"id":"sb:o/556c1a0dbef87bc42037067b","kind":"observation","label":"The ASCO Post · 2026-09-14 · Perioperative Atezolizumab Plus Chemotherapy Improves Outcomes in Resectable Stage II–IIIB NSCLC","url":"https://ascopost.com/news/september-2026/perioperative-atezolizumab-plus-chemotherapy-improves-outcomes-in-resectable-stage-ii-iiib-nsclc/"},{"id":"sb:o/fff8b5fb66ee0bdc949be0ca","kind":"observation","label":"The ASCO Post · 2026-09-14 · General Email","url":"https://ascopost.com/tap-en-emails/general-email/"}],"cursor":null,"order":"newest first; we keep the 6 newest receipts for this entity whose own title or summary lead (the entity graph's test) names it. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":10,"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with lung cancer (17 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/ffdecd256039c42751a6c56e"},{"kind":"relation","label":"co-mentioned with iaslc (12 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/c740b3dcf4f8c66aaa0dae86"},{"kind":"relation","label":"co-mentioned with wclc (12 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/0a5049736df9ece6740d9c08"},{"kind":"relation","label":"co-mentioned with egfr (12 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/f4a423c68b5991a23ebd8d66"},{"kind":"relation","label":"co-mentioned with cancer center (11 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/f281aba1fb14a81281344816"},{"kind":"relation","label":"co-mentioned with egfr-mutated (9 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/279df0061e37c81716b3edbd"},{"kind":"relation","label":"co-mentioned with her2 (9 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/adbf9e998c4ff836eec07e8f"},{"kind":"relation","label":"co-mentioned with her2-mutant (8 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/f82e77425c78cbcdedf77c05"},{"kind":"relation","label":"co-mentioned with dana-farber cancer institute (8 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/d7f7dc35c12e4fc62adc11dd"},{"kind":"relation","label":"co-mentioned with iiia (8 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/3755985bd5e7ad7a879a6409"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/cd30f295b64ab8277556ea54","mcp":"traverse {\"id\":\"sb:e/cd30f295b64ab8277556ea54\"}","page":"/entity/iiib/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/cd30f295b64ab8277556ea54\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/cd30f295b64ab8277556ea54\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/cd30f295b64ab8277556ea54\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/cd30f295b64ab8277556ea54\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}